NeuroGlove Anxiety and Depression Study

Description

This is a prospective, homebased, interventional clinical study containing 10 subjects who will be enrolled. Approximately 10 (10) subjects with active anxiety and depression symptoms will receive treatment using the NeuroGlove.

Conditions

Anxiety, Depression, Anxiety Depression, Depression, Anxiety

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective, homebased, interventional clinical study containing 10 subjects who will be enrolled. Approximately 10 (10) subjects with active anxiety and depression symptoms will receive treatment using the NeuroGlove.

Impact of Peripheral Sensory Stimulation of the Hand and Synchronized Deep Breathing in the Treatment of Anxiety and Depression: Assessing Safety and Effectiveness

NeuroGlove Anxiety and Depression Study

Condition
Anxiety
Intervention / Treatment

-

Contacts and Locations

Minneapolis

NeuroGlove, Minneapolis, Minnesota, United States, 55416

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
  • * Men and women ≥18 and \<85 years of age.
  • * Carry an active diagnosis of anxiety and/or depression.
  • * Suffer from anxiety and/or depression symptoms that impact subject's daily activities and quality of life.
  • * Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
  • * The subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
  • * Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NeuroGlove LLC,

Eric Nussbaum, MD, PRINCIPAL_INVESTIGATOR, NeuroGlove LLC

Study Record Dates

2024-11-01